Projects per year
Personal profile
Biography
Julia van der Hoven completed her Bachelor of Science majoring in physiology and pharmacology at The University of Sydney in 2011. In 2012, she completed her Honours project on investigating the spreading of tau protein pathology under the supervision of Prof Lars Ittner. After working in community pharmacy, she rejoined the Ittner lab to begin her PhD in 2016 and following it's completion in 2021 she continues her research with the Dementia Research Centre.
Research interests
Julia's PhD project was based on the role of the immune system in Alzheimer's disease and she continues to investigate this interest. During her PhD she concurrently completed her Masters of Public Health at UNSW to diversify her research knowledge and skills to include epidemiological and population-based studies.
Education/Academic qualification
Public Health & Community Medicine, Masters, The University of New South Wales
23 Feb 2015 → 2019
Science, BSc (Hons), University of Sydney
23 Feb 2009 → 21 Dec 2012
Fingerprint
Dive into the research topics where Julia van der Hoven is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
2022 NHMRC Ideas: Inhibition failure in Alzheimer's disease
Ittner, L., van der Hoven, J., Deng, Y., Forrest, S., Ke, Y. & Kovacs, G.
1/01/23 → 31/12/26
Project: Research
-
An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting
Wong, C. Y. J., Baldelli, A., Tietz, O., van der Hoven, J., Suman, J., Ong, H. X. & Traini, D., 10 Apr 2024, In: International Journal of Pharmaceutics. 654, p. 1-12 12 p., 123922.Research output: Contribution to journal › Review article › peer-review
Open AccessFile3 Citations (Scopus)73 Downloads (Pure) -
Design of peptide therapeutics as protein-protein interaction inhibitors to treat neurodegenerative diseases
Ariawan, D., Pushpitha, K. P. M., El-Omar, A., van der Hoven, J., Genoud, S., Stefen, H., Fath, T., van Eersel, J., Ittner, L. M. & Tietz, O., 30 Oct 2024, In: RSC Advances. 14, 47, p. 34637-34642 6 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile10 Downloads (Pure) -
Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice
Ke, Y. D., van Hummel, A., Au, C., Chan, G., Lee, W. S., van der Hoven, J., Przybyla, M., Deng, Y., Sabale, M., Morey, N., Bertz, J., Feiten, A., Ippati, S., Stevens, C. H., Yang, S., Gladbach, A., Haass, N. K., Kril, J. J., Blair, I. P., Delerue, F., & 1 others, 17 Apr 2024, In: Neuron. 112, 8, p. 1249-1264.e8 25 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models
van Hummel, A., Sabale, M., Przybyla, M., van der Hoven, J., Chan, G., Feiten, A. F., Chung, R. S., Ittner, L. M. & Ke, Y. D., Apr 2023, In: Neuropathology and Applied Neurobiology. 49, 2, p. 1-12 12 p., e12902.Research output: Contribution to journal › Article › peer-review
Open AccessFile82 Downloads (Pure) -
Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease
Deng, Y., Bi, M., Delerue, F., Forrest, S. L., Chan, G., van der Hoven, J., van Hummel, A., Feiten, A. F., Lee, S., Martinez-Valbuena, I., Karl, T., Kovacs, G. G., Morahan, G., Ke, Y. D. & Ittner, L. M., Oct 2022, In: Acta Neuropathologica. 144, 4, p. 637-650 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile18 Citations (Scopus)79 Downloads (Pure)